What Nurix Therapeutics, Inc. pays on H-1B filings

Nurix Therapeutics, Inc. filed 18 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.

FY2026 so far · 5 LCAsFY2025 · 13 LCAs

Stated wages by title

TitleLCAsYearTypical rangeMedian
Research Associate5FY2025$114,500 to $115,000$115,000
Associate Director4FY2025$140,000 to $166,250$152,500

Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.

Filings by fiscal year

Fiscal yearCertified LCAs
FY2026 (October to June)5
FY202513

By prevailing-wage level

LevelLCAsMedian stated wage
Level II (qualified)6$115,000
Level III (experienced)8$140,000
Level IV (fully competent)4$165,000

DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.

Top worksites

WorksiteLCAsMedian stated wage
San Francisco, CA9$140,000
Brisbane, CA5$150,000
Menlo Park, CA1$140,000
Monrovia, MD1$140,000

Looking at Nurix Therapeutics, Inc.?

Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.